Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
Cytek Biosciences (Nasdaq: CTKB), a leading cell analysis solutions company, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management will deliver a presentation on Thursday, January 16th at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time).
Investors and interested parties can access both live and archived versions of the presentation through the 'Investors' section of Cytek's website at investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), un'azienda leader nelle soluzioni di analisi cellulare, ha annunciato la sua partecipazione alla 43ª Conferenza Sanitaria Annuale J.P. Morgan a San Francisco. La direzione dell'azienda farà una presentazione giovedì 16 gennaio alle 8:15 ora del Pacifico (11:15 ora dell'Est).
Investitori e parti interessate possono accedere sia alla versione in diretta che a quella archiviata della presentazione nella sezione 'Investitori' del sito web di Cytek all'indirizzo investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), una empresa líder en soluciones de análisis celular, ha anunciado su participación en la 43.ª Conferencia Anual de Salud de J.P. Morgan en San Francisco. La dirección de la empresa realizará una presentación el jueves 16 de enero a las 8:15 a.m. hora del Pacífico (11:15 a.m. hora del Este).
Los inversores y partes interesadas pueden acceder tanto a la versión en vivo como a la archivada de la presentación a través de la sección 'Inversores' del sitio web de Cytek en investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), 선도적인 세포 분석 솔루션 회사가 샌프란시스코에서 열리는 제43회 J.P. Morgan 의료 회의에 참가한다고 발표했습니다. 회사 경영진은 1월 16일 목요일 오전 8시 15분(동부 표준시 오전 11시 15분)에 발표를 진행할 것입니다.
투자자와 이해관계자는 Cytek 웹사이트의 '투자자' 섹션에서 생중계 및 아카이브된 프레젠테이션 모두에 액세스할 수 있습니다: investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), une entreprise leader dans les solutions d'analyse cellulaire, a annoncé sa participation à la 43e Conférence Annuelle de Santé J.P. Morgan à San Francisco. La direction de l'entreprise fera une présentation le jeudi 16 janvier à 8h15, heure du Pacifique (11h15, heure de l'Est).
Les investisseurs et les parties intéressées peuvent accéder à la version en direct et archivée de la présentation via la section 'Investisseurs' du site Web de Cytek à l'adresse investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB), ein führendes Unternehmen für Zellanalyselösungen, hat seine Teilnahme an der 43. J.P. Morgan Gesundheitskonferenz in San Francisco bekanntgegeben. Die Unternehmensführung wird am Donnerstag, den 16. Januar, um 8:15 Uhr pazifischer Zeit (11:15 Uhr östlicher Zeit) eine Präsentation halten.
Investoren und interessierte Parteien können sowohl auf die Live- als auch auf die archivierte Version der Präsentation über den Bereich 'Investoren' auf der Website von Cytek unter investors.cytekbio.com zugreifen.
- None.
- None.
FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Cytek management is scheduled to present on Thursday, January 16th at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: investors.cytekbio.com.
About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes its core FSP instruments, the Cytek Aurora™ and Northern Lights™ systems and its Cytek Aurora CS cell sorter; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
pgoodson@cytekbio.com
FAQ
When is Cytek Biosciences (CTKB) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Cytek Biosciences' (CTKB) J.P. Morgan Healthcare Conference presentation?
Where is the 2025 J.P. Morgan Healthcare Conference featuring Cytek Biosciences (CTKB) being held?
What time is Cytek Biosciences' (CTKB) presentation in Eastern Time?
